Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ORIC Oric Pharmaceuticals

3.170
+0.020+0.63%
Close 09/27 16:00 ET
High
3.370
Open
3.260
Turnover
910.29K
Low
3.040
Pre Close
3.150
Volume
282.23K
Market Cap
125.46M
P/E(TTM)
Loss
52wk High
20.910
Shares
39.58M
P/E(Static)
Loss
52wk Low
2.620
Float Cap
92.57M
Bid/Ask %
0.00%
Historical High
40.810
Shs Float
29.20M
Volume Ratio
1.57
Historical Low
2.620
Dividend TTM
--
Div Yield TTM
--
P/B
0.53
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.97%
Amplitude
10.48%
Avg Price
3.225
Lot Size
1
Float Cap
92.57M
Bid/Ask %
0.00%
Historical High
40.810
Shs Float
29.20M
Volume Ratio
1.57
Historical Low
2.620
Dividend TTM
--
P/B
0.53
Dividend LFY
--
Turnover Ratio
0.97%
Amplitude
10.48%
Avg Price
3.225
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
CEO: Mr. Jacob M. Chacko, M.B.A.,M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...